D. J. Wardrop et al. / Tetrahedron: Asymmetry 14 (2003) 929–940
937
Hz, 1H), 2.61 (d, J=7.5 Hz, 1H), 2.45 (d, J=18.2 Hz,
1H), 1.94 (q, J=7.6 Hz, 2H), 1.35 (s, 3H), 1.09 (q,
J=7.6 Hz, 2H), 0.91 (t, J=7.6 Hz, 3H), 0.77 (t, J=7.6
Hz, 3H); 13C (100 MHz, CDCl3) l 211.6, 128.3, 98.0,
69.4, 37.5, 37.1, 23.3, 22.8, 18.0, 7.5, 6.4; high-resolu-
tion mass spectrum (CI) m/z 199.1333 [(M+H)+; calcd
for C11H19O3 199.1334].
NMR) of C-4 and C-6 CꢀH insertion products (110 mg,
54%): colorless oil: Rf 0.20 (EtOAc/hexanes, 1:9); IR
(film) 2936, 2344, 1754, 1445, 1376, 1173, 1102, 665
cm−1; 1H NMR (400 MHz, CDCl3) l 4.81–4.78 (m,
1H), 4.05–3.88 (m, 3H), 2.72 (dd, J=17.9, 7.5 Hz, 1H),
2.36–2.26 (m, 3H), 2.17–2.15 (m, 1H), 2.04–2.00 (m,
1H), 1.59–1.56 (m, 2H), 1.55 (s, 3H), 1.45 (s, 6H), 1.35
(d, J=6.1 Hz, 3H); 13C (100 MHz, CDCl3) l 211.9,
211.4, 100.6, 98.5, 71.7, 66.7, 61.8, 45.8, 40.26, 37.1,
35.2, 26.5, 22.3, 18.8; high-resolution mass spectrum
(CI) m/z 157.0875 [(M+H)+; calcd for C8H13O3
157.0865].
4.5.6. ( )-4,4-Diethyl-1-methyl-7-methylene-2,6,8-trioxa-
bicyclo[3.2.1]octane, 4c. (20 mg, 12%) colorless oil; Rf
0.51 (EtOAc/hexanes, 1:9); IR (film) 2966, 2876, 1689,
1
1390, 1336, 1201, 1125, 958, 911, 855, 743 cm−1; H
NMR (400 MHz, CDCl3) l 5.35 (s, 1H), 4.44 (d, J=2.4
Hz, 1H), 4.11 (d, J=2.4 Hz, 1H), 3.62 (d, J=11.5 Hz,
1H) 3.58 (d, J=11.5 Hz, 1H), 1.74 (q, J=7.6 Hz, 2H),
1.55 (s, 3H), 1.34 (q, J=7.6 Hz, 2H), 0.88 (t, J=7.6 Hz,
3H), 0.80 (t, J=7.6 Hz, 3H); 13C (100 MHz, CDCl3) l
157.1, 105.8, 101.9, 80.0, 69.5, 40.0, 29.9, 22.8, 20.6, 7.8,
6.6; high-resolution mass spectrum (CI) m/z 199.1334
[(M+H)+; calcd for C11H19O3 199.1334].
4.5.11. ( )-(1a,3a,5a)-1,4-Dimethyl-4-nitro-2,8-dioxabi-
cyclo[3.2.1]octan-7-one, 2g. (21 mg, 27%): colorless oil;
Rf 0.42; (EtOAc/hexanes, 1:1); IR (film) 2934, 1767,
1
1536, 1387, 1178, 1082, 859, 804, 481 cm−1; H NMR
(400 MHz, CDCl3) l 4.97 (d, J=7.6 Hz, 1H), 4.20 (d,
J=12.8 Hz, 1H), 4.10 (d, J=12.8 Hz, 1H), 2.85 (dd,
J=19.0, 7.6 Hz, 1H), 2.28 (d, J=19.0 Hz, 1H), 2.03 (s,
3H), 1.42 (s, 3H); 13C (100 MHz, CDCl3) l 207.4, 98.8,
81.1, 76.0, 66.0, 38.2, 23.7, 17.5; high-resolution mass
spectrum (CI) m/z 219.0971 [(M+NH4)+; calcd for
C8H15N2O5 219.0981].
4.5.7.
( )-1-Methyl-2,8-dioxaspiro[4.5]bicyclo[3.2.1]-
octan-7-one, 3d. (90 mg, 50%): white solid; mp 65–66°C;
Rf 0.30 (EtOAc/hexanes, 2:5); IR (KBr) 2952, 2864,
1
1765, 1448, 1179, 1102, 864 cm−1; H NMR (400 MHz,
CDCl3) l 4.30 (d, J=7.4 Hz, 1H), 3.65 (d, J=13.2 Hz,
1H), 3.57 (d, J=13.2 Hz, 1H), 2.66 (dd, J=18.2, 7.4
Hz, 1H), 2.29 (d, J=18.2 Hz, 1H), 2.16–2.06 (m, 1H),
1.89–1.87 (m, 1H), 1.78–1.74 (m, 1H), 1.66–1.56 (m,
3H), 1.40 (s, 3H), 1.38–1.25 (m, 1H), 1.08–1.03 (m, 1H);
13C (100 MHz, CDCl3) l 211.6, 98.2, 80.1, 70.67, 45.0,
38.9, 36.5, 32.5, 25.6, 25.1, 18.2; high-resolution mass
spectrum (CI) m/z 197.1162 [(M+H)+; calcd for
C11H17O3 197.1178].
4.5.12. ( )-(4-Benzyloxymethyl-1-methyl-7-oxo-2,8-dioxa-
bicyclo[3.2.1]oct-4-yl)-carbamic acid benzyl ester, 8. (365
mg, 43%); colorless oil; Rf 0.65 (EtOAc/hexanes, 1:1);
IR (film) 3352, 3030, 2936, 2874, 1767, 1716, 1526,
1
1453, 1384, 1250, 1180, 1073, 1028, 739, 697 cm−1; H
NMR (500 MHz, CDCl3) l 7.28–7.14 (m, 10H), 5.50 (s,
1H), 5.13 (d, J=12.2 Hz, 1H), 5.10 (d, J=12.2 Hz,
1H), 4.82 (d, J=7.6 Hz, 1H), 4.51 (d, J=12.0 Hz, 1H),
4.42 (d, J=12.0 Hz, 1H), 4.14 (d, J=12.9 Hz, 1H), 3.79
(d, J=10.1 Hz, 1H), 3.56 (d, J=12.9 Hz, 1H), 3.56 (d,
J=10.1 Hz, 1H), 2.69 (dd, J=7.6, 18.7 Hz, 1H), 2.60
(d, J=18.7 Hz, 1H), 1.38 (s, 3H); 13C (125 MHz,
CDCl3) l 209.7, 155.4, 137.6, 136.4, [(128.8, 128.7,
128.4, 128.3, 127.9, (10 C)], 98.6, 75.4, 73.8, 68.0, 66.9,
65.2, 55.5, 37.7, 18.1; high-resolution mass spectrum
(CI) m/z 412.17594 [(M+H)+; calcd for C23H26O6N,
412.17601].
4.5.8. ( )-4-Spiro[4.5]-1-methyl-7-methylene-2,6,8-trioxa-
bicyclo[3.2.1]octane, 4d. (20 mg, 11%): colorless oil; Rf
0.66 (EtOAc/hexanes, 2:5); IR (film) 2955, 2866, 1688,
1453, 1369, 1333, 1198, 1122, 1022, 959, 910, 742 cm−1;
1H NMR (400 MHz, CDCl3) l 5.25 (s, 1H), 4.56 (d,
J=4.2 Hz, 1H), 4.13 (d, J=4.2 Hz, 1H), 3.79 (d,
J=11.2 Hz, 1H), 3.51 (d, J=11.2 Hz, 1H), 1.72–1.63
(m, 1H), 1.61–1.58 (m, 2H), 1.52 (s, 3H), 1.49–1.48 (m,
2H), 1.28–1.26 (m, 1H), 1.06–0.90 (m, 1H), 0.89–0.86
(m, 1H); 13C (100 MHz, CDCl3) l 157.2, 107.4, 101.7,
80.2, 70.6, 46.5, 34.0, 32.1, 25.6, 25.2, 20.6; high-resolu-
tion mass spectrum (CI) m/z 197.1165 [(M+H)+; calcd
for C11H17O3 197.1178].
4.6. Total synthesis of 7-episordidin, 13b
4.6.1. trans-2-Cyano-2-ethyl-cis-4,6-dimethyl-1,3-diox-
ane, 17. To a stirred solution of meso-2,4-propanediol
14 (650 mg, 6.25 mmol) and p-TsOH (25 mg, 0.13
mmol) in CH2Cl2 (40 mL) at rt was added triethyl
orthopropionate (1.83 mL, 9.38 mmol) and the reaction
stirred for 3 h. Trimethylsilyl cyanide (3.10 g, 31.25
mmol) (CAUTION!) and BF3·Et2O (159 mL, 1.27
mmol) were then sequentially added and the resulting
mixture stirred for an additional 16 h at rt. The reac-
tion was then quenched with powdered anhydrous
K2CO3 (1.5 g), stirred for 20 min then filtered through
a pad of Celite. The filtrate was then concentrated
under reduced pressure to provide 17 (1.04 g, 99%).
Analysis of this material by 1H NMR spectroscopy
indicated that it was of sufficient purity to allow direct
submission to hydrolysis: yellow oil; IR (film) 3071,
4.5.9. ( )-1-Methyl-2,8-dioxabicyclo[3.2.1]octan-7-one,
2e. (70 mg, 44%): clear oil; Rf 0.33 (EtOAc/hexanes,
2:5); IR (film) 2977, 2939, 1760, 1383, 1181, 1092, 919,
1
842, 740 cm−1; H NMR (400 MHz, CDCl3) l 4.79 (m,
1H), 4.00–3.93 (m, 2H), 2.71 (dd, J=18.3, 7.8, Hz, 1H),
2.51–2.47 (m, 1H), 2.27 (d, J=18.3 Hz, 1H), 1.43 (m,
1H), 1.29 (s, 3H); 13C (100 MHz, CDCl3) l 211.2, 98.4,
71.7, 60.9, 39.7, 29.3, 18.7; high-resolution mass spec-
trum (CI) m/z 143.0715 [(M+H)+; calcd for C7H11O3
143.0708].
4.5.10. ( )-(1a,5ab)-1,5-Dimethyl-2,8-dioxabicyclo[3.2.1]-
octan - 7 - one/(1a,3ab) - 1,3 - dimethyl - 2,8 - dioxabicyclo-
[3.2.1]octan-7-one, 2f. Inseparable mixture (1:1, 1H
1
2930, 2872, 2260, 1449, 1360, 1209, 1098, 922 cm−1; H